Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Physitrack Gelecekteki Büyüme

Future kriter kontrolleri 1/6

Physitrack'in gelirinin artacağı tahmin edilmektedir.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Healthcare Services kazanç büyümesi	25.7%
Gelir büyüme oranı	19.6%
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	Low
Son güncelleme	14 Aug 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

OM:PTRK - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (EUR Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	25	N/A	N/A	N/A	1
12/31/2025	20	N/A	N/A	6	1
12/31/2024	17	N/A	N/A	4	1
6/30/2024	16	3	0	3	N/A
3/31/2024	16	3	0	3	N/A
12/31/2023	15	3	-1	3	N/A
9/30/2023	15	0	-2	2	N/A
6/30/2023	14	0	-2	2	N/A
3/31/2023	14	0	-3	2	N/A
12/31/2022	13	0	-3	1	N/A
9/30/2022	11	0	-3	1	N/A
6/30/2022	10	0	-3	0	N/A
3/31/2022	9	-1	-2	0	N/A
12/31/2021	8	-1	-1	1	N/A
11/30/2021	8	-1	-1	1	N/A
8/31/2021	6	-1	0	1	N/A
5/31/2021	5	1	1	2	N/A
2/28/2021	4	1	1	2	N/A
11/30/2020	3	1	1	2	N/A
11/30/2019	1	0	0	1	N/A
11/30/2018	1	0	N/A	N/A	N/A
11/30/2017	0	0	N/A	N/A	N/A
11/30/2016	0	0	N/A	N/A	N/A
11/30/2015	0	0	N/A	N/A	N/A
11/30/2014	0	0	N/A	N/A	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: PTRK 'un tahmini kazanç büyümesinin tasarruf oranının ( 1.1% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: PTRK 'un kazançlarının Swedish pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: PTRK şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: PTRK şirketinin gelirinin (yıllık 19.6% ) Swedish pazarından (yıllık 1.4% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: PTRK şirketinin gelirinin (yıllık 19.6% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: PTRK 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Physitrack Gelecekteki Büyüme

Future kriter kontrolleri 1/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Consensus EPS estimates upgraded to €0.025 loss

Physitrack PLC Provides Earnings Guidance

Recent updates

Second quarter 2024 earnings released: €0.029 loss per share (vs €0.015 loss in 2Q 2023)

Investor sentiment improves as stock rises 16%

Investors Aren't Entirely Convinced By Physitrack PLC's (STO:PTRK) Revenues

Chairman & Senior Independent Director recently bought kr57k worth of stock

First quarter 2024 earnings released: €0.01 loss per share (vs €0.004 loss in 1Q 2023)

Investor sentiment improves as stock rises 16%

Physitrack (STO:PTRK) Is Doing The Right Things To Multiply Its Share Price

Physitrack (STO:PTRK) Has A Somewhat Strained Balance Sheet

New minor risk - Earnings quality

Investor sentiment deteriorates as stock falls 18%

Full year 2023 earnings released: EPS: €0.20 (vs €0.006 in FY 2022)

Physitrack PLC (STO:PTRK) Could Be Riskier Than It Looks

Physitrack PLC, Annual General Meeting, May 03, 2024

Physitrack PLC to Report Q4, 2024 Results on Feb 28, 2025

New minor risk - Share price stability

Third quarter 2023 earnings released: €0.01 loss per share (vs €0.001 profit in 3Q 2022)

Revenues Tell The Story For Physitrack PLC (STO:PTRK)

Why Physitrack PLC (STO:PTRK) Could Be Worth Watching

Second quarter 2023 earnings released: €0.015 loss per share (vs €0.026 loss in 2Q 2022)

New minor risk - Share price stability

Physitrack plc Announces Board Changes

Physitrack PLC Announces Appointment of Jack Goodwin as Head of People

Physitrack PLC Approves Election of Anne-Sophie D'andlau as Director

First quarter 2023 earnings released

Independent Non-Executive Director recently bought kr56k worth of stock

Consensus EPS estimates upgraded to €0.025 loss

Full year 2022 earnings released: EPS: €0.01 (vs €0.06 loss in FY 2021)

Be Wary Of Physitrack (STO:PTRK) And Its Returns On Capital

Physitrack PLC Appoints Nick McClelland to Take on A New Role as Chief Growth Officer

High number of new and inexperienced directors

Physitrack PLC Announces the Appoints Anne-Sophie d'Andlau as Board Member

Third quarter 2022 earnings released: EPS: €0.001 (vs €0.07 loss in 3Q 2021)

Physitrack PLC to Report Q2, 2023 Results on Aug 15, 2023

Physitrack (STO:PTRK) Will Be Hoping To Turn Its Returns On Capital Around

Henrik Molin, Chief Executive Officer and Co-founder of Physitrack PLC acquired an additional 4.3% stake in Physitrack PLC (OM : PTRK) from Nathan Skwortsow, co-founder of Physitrack PLC for €1 million.

Second quarter 2022 earnings released: €0.02 loss per share (vs €0.011 loss in 2Q 2021)

Physitrack plc Recruits Announces Management Changes

Chief Operating Officer recently bought kr56k worth of stock

First quarter 2022 earnings: Revenues miss analyst expectations

Physitrack PLC (OM:PTRK) acquired Champion Health Ltd from Harry Bliss and Ricky Bailey for £10.4 million.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Chief Financial Officer recently bought kr62k worth of stock

Physitrack PLC (OM:PTRK) acquired Wellnow Group GmbH from Axel Springer Plug and Play Accelerator GmbH and Tengelmann Ventures Management GmbH for €11.5 million.

Physitrack PLC (OM:PTRK) acquired Wellnow Group GmbH from Axel Springer Plug and Play Accelerator GmbH and Tengelmann Ventures Management GmbH for €11.5 million.

Full year 2021 earnings: EPS exceeds analyst expectations

Physitrack PLC Provides Earnings Guidance

Investor sentiment improved over the past week

Physitrack PLC has completed an IPO in the amount of SEK 175 million.

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin